Digital Health, Artificial Intelligence & Internet of Everything
We empower clients to capitalize on Digital Health, AI, and IoE - accelerating success in these emerging fields. Leveraging robust research capabilities, we deliver strategic insights enabling partners to build winning solutions and gain a competitive edge.
We empower Pharma, Biotech, Healthcare and HealthTech/MedTech companies to capitalize on Digital Health, AI and IoE, accelerating their competitive advantage.
As trusted partners, we provide strategic support spanning areas such as:
- Collaborative projects with BioPharma innovation units and patient solution teams
- Intensive patient-centricity research, placing the end-user at the heart of every solution
- Trend analysis in AI, wearable tech, digital therapeutics, and comprehensive digital health solutions
- Creation and support in AI-powered tool development for enhanced data intelligence
- Joint strategy formulation for competitive digital health and AI initiatives
- Pioneering research on the transformative impact of AI/IoE on healthcare, from “smart” homes to “smart” appliances
With robust research and consulting, we deliver evidence-based solutions, enabling clients to implement winning digital strategies.
Ready to accelerate innovation?
Let’s build winning tech strategies together. Contact us at info@lqventures.com.
July 30, 2026
Cell and Gene Therapy Strategic Roundup | June 24–July 29, 2026
July 28, 2026
Massive Bio and GELL Partnership | Lucid Diligence Brief
July 28, 2026
Obesity Strategic Roundup | June 22–July 27, 2026
July 23, 2026
Cardiovascular Strategic Roundup | June 25–July 21, 2026
July 23, 2026
Evogene and ELEO Oral PCSK9 Collaboration | Lucid Diligence Brief
July 22, 2026
Neuroscience Strategic Roundup | June17–July 21, 2026
July 21, 2026
Endocrinology Strategic Roundup | June 23–July 20, 2026
July 20, 2026